[1]
Janku, F. et al. 2002. Efficacy of weekly trastuzumab and paclitaxel in the treatment of women with HER-2/neu overexpressing metastatic breast cancer. The impact of taxane free interval on treatment outcomes. Radiology and Oncology. 36, 2 (Jun. 2002).